Scientific work

Uzm. Dr. Kadriye Başkurt

61 publications. The source of the information is stated next to each publication.

Back to profile

  1. Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104936 PMID 42777557 Open-access full textSource: ORCID

  2. Serum Vitamin D as a Predictor of Immunotherapy Response in Advanced Non-small Cell Lung Cancer

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-4-7 Open-access full textSource: OpenAlex

  3. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

    Clinical Colorectal Cancer, 2026

    DOI 10.1016/j.clcc.2025.10.002 PMID 41198426 1 citation (Europe PMC) Source: ORCID

  4. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag396 PMID 42836684 Open-access full textSource: Europe PMC

  5. Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12075 Source: OpenAlex

  6. Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-8-2 Open-access full textSource: OpenAlex

  7. Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15922 Open-access full textSource: OpenAlex

  8. Structural Acceleration in Sepsis-Associated Cancer Mortality in an Aging Population: A Nationwide Study in the United States, 1999–2020

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.6201853 Open-access full textSource: OpenAlex

  9. Temporal trends in venous thromboembolism–related mortality among gastric cancer deaths in the United States, 1999–2020.

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1893840 Open-access full textSource: OpenAlex

  10. Temporal Trends and Demographic Disparities in Prostate Cancer Mortality in the United States, 1999-2020: A CDC WONDER Analysis

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-8-1 Open-access full textSource: OpenAlex

  11. Temporal Trends and Structural Acceleration in Nutritionand Cachexia-Associated Mortality Among Pancreatic Cancer Decedents in the United States, 1999–2020: A Nationwide Population-Based Joinpoint Analysis

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.269441 Source: ORCID

  12. Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11216-6 PMID 42726154 Source: OpenAlex

  13. Re: Factors associated with employment outcomes in cancer survivors: a systematic scoping review spanning a decade of international research

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-10716-9 PMID 42043612 Source: Europe PMC

  14. Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026

    DOI 10.1007/s12094-025-04194-4 PMID 41525036 2 citations (Europe PMC) Source: Europe PMC

  15. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial)

    International journal of cancer, 2026

    DOI 10.1002/ijc.70601 PMID 42311202 Open-access full textSource: Europe PMC

  16. Limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers: A prospective self-controlled study (NEURO-GLOVE Trial)—Updated long-term analysis.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.5545 Source: OpenAlex

  17. Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study

    JCO Global Oncology, 2026

    DOI 10.1200/go-26-00151 PMID 42623594 Open-access full textSource: OpenAlex

  18. Histologic Subtypes, Treatment Patterns, and Survival Outcomes in Cervical Cancer: A Population-based SEER Study

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-7-1 Open-access full textSource: OpenAlex

  19. Impact of Zinc Supplementation and Topical Clobetasol on the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction: The ZINCLO-HAND Study

    JCO Oncology Practice, 2026

    DOI 10.1200/op-26-00226 Source: OpenAlex

  20. Association between PhenoAge-assessed biological age and survival outcomes in solid tumor patients treated with immune checkpoint inhibitors

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05792-6 Open-access full textSource: ORCID

  21. Peer-led culinary workshops for cancer survivors: feasibility achieved, but stronger nutritional and evaluative foundations are required

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11053-7 PMID 42521889 Source: ORCID

  22. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey

    Current Oncology, 2026

    DOI 10.3390/curroncol33060340 PMID 42346239 1 citation (Europe PMC) Open-access full textSource: ORCID

  23. Expanding perspectives on informed decision-making in pancreatic cancer

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-10762-3 PMID 42090036 Source: ORCID

  24. Granülosit koloni stimülan faktörün yaygın evre küçük hücreli akciğer kanserinde etkinlik ve güvenilirliğinin retrospektif analizi

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1800650 Open-access full textSource: ORCID

  25. Metastatik/inoperabl pankreatikobilier sistem kanserlerinde ikinci basamak kemoterapilerin etkinlik ve güvenlilik sonuçları: tek merkez retrospektif çalışma

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1792552 Open-access full textSource: ORCID

  26. Trends in Overall Survival and Associated Factors in Metastatic Rectal and Rectosigmoid Cancer: A SEER-Based Cohort Study (2000-2022)

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-10-11 Open-access full textSource: OpenAlex

  27. Comment on: “The effect of cancer response style on anxiety and depression levels in newly diagnosed lung cancer patients”

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11316-3 PMID 42842009 Source: OpenAlex

  28. Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15932 Open-access full textSource: OpenAlex

  29. Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e15507 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  30. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  31. 3060eP Immunomodulatory effect of cisplatin versus carboplatin on tumor microenvironment and anti-PD-1 response: A multicenter real-world analysis

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3673 Open-access full textSource: OpenAlex

  32. Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2598042 PMID 41451788 Source: OpenAlex

  33. Vitamin D serum level as a predictor of response to immunotherapy for non-small cell lung cancer.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e14563 Open-access full textSource: OpenAlex

  34. The Impact of Systemic Inflammation and Nutritional Indicators on Progression-Free Survival in Patients with Metastatic Clear Cell Renal Carcinoma Receiving First-Line Tyrosine Kinase Inhibitor Therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1822329 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  35. 2881P Integrating inflammatory, nutritional, and sarcopenia-based biomarkers for predicting pathological response in rectal cancer patients receiving total neoadjuvant therapy: A regression and AI-supported approach

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3493 Open-access full textSource: OpenAlex

  36. 2864P Assessment of inflammation, nutrition and cachexia-related indices to predict 90-day mortality in hospitalized cancer patients

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3476 Open-access full textSource: OpenAlex

  37. 2814P AI-supported evaluation of clinical and biological risk indicators in cancer patients with unplanned hospitalisations

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3426 Open-access full textSource: OpenAlex

  38. Compression therapy for taxane-induced peripheral neuropathy: promising results undermined by methodological gaps

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10036-4 PMID 41099870 Source: ORCID

  39. Prognostic beliefs in palliative care: clarifying constructs, communicators, and consequences

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10060-4 PMID 41165945 Source: ORCID

  40. Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer

    Clinical and Translational Oncology, 2025

    DOI 10.1007/s12094-025-04070-1 PMID 41053526 3 citations (Europe PMC) Source: ORCID

  41. Letter to the Editor: Comment on “Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy”

    Nutrition and Cancer, 2025

    DOI 10.1080/01635581.2025.2514277 PMID 40481654 Source: ORCID

  42. Dissecting component-specific and sustained benefits of integrated psychosocial–nutritional care in gastric oncology

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09652-x PMID 40512231 Source: ORCID

  43. Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores

    The Lancet Regional Health - Europe, 2025

    DOI 10.1016/j.lanepe.2025.101317 PMID 40672056 11 citations (Europe PMC) Open-access full textSource: ORCID

  44. Letter RE: Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high-grade serous carcinoma

    European Journal of Cancer, 2025

    DOI 10.1016/j.ejca.2025.115490 PMID 40335330 Source: ORCID

  45. Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial

    European Journal of Cancer, 2025

    DOI 10.1016/j.ejca.2025.115408 PMID 40215593 17 citations (Europe PMC) Source: ORCID

  46. Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10157-w PMID 41238950 1 citation (Europe PMC) Source: ORCID

  47. Unaccounted clinical factors in CINV outcomes: the missing role of IO therapy, metastatic sites, and prophylaxis strategy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09631-2 PMID 40498135 Source: OpenAlex

  48. The Effect of Malnutrition on Treatment Efficacy and Toxicity in Geriatric Patients Treated With Immune Checkpoint Inhibitors

    Cancer Diagnosis & Prognosis, 2025

    DOI 10.21873/cdp.10491 PMID 41179320 Open-access full textSource: OpenAlex

  49. 2865P Association of skeletal muscle and visceral FDG uptake with cancer cachexia, nutritional status, and survival in small cell lung cancer

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3477 Open-access full textSource: OpenAlex

  50. 2867P Evaluation of the relationship between sarcopenia and paclitaxel toxicity in early stage breast cancer patients receiving adjuvant/neoadjuvant paclitaxel

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3479 Open-access full textSource: OpenAlex